Morgan Stanley Capital Partners sells Clarity Software Solutions to mPulse

Published 27/08/2025, 14:06
Morgan Stanley Capital Partners sells Clarity Software Solutions to mPulse

NEW YORK - Morgan Stanley Capital Partners (MSCP), a division of Morgan Stanley (NYSE: MS) - currently trading near its 52-week high with a market capitalization of $237.63 billion - announced Wednesday it has completed the sale of Clarity Software Solutions to mPulse. Financial terms of the transaction were not disclosed. According to InvestingPro data, Morgan Stanley has demonstrated robust performance with a 50.29% return over the past year.

Connecticut-based Clarity provides health plan member communication services to health insurance providers, third-party administrators, and dental insurance companies. The company specializes in multimodal communications and engagement solutions aimed at streamlining processes and helping healthcare organizations meet regulatory requirements.

MSCP initially invested in Clarity in 2019. During its ownership period, MSCP focused on enhancing Clarity’s product development and technology innovation while strengthening the management team with key hires. The parent company Morgan Stanley has shown strong financial health, maintaining a solid current ratio of 2.14 and achieving revenue growth of 16.92% in the last twelve months. InvestingPro subscribers have access to 12 additional key insights about Morgan Stanley’s performance and valuation metrics.

"We’re proud to have partnered with the team at Clarity to help accelerate their business objectives to help healthcare organizations enhance and further personalize their member communications," said Steve Rodgers, Managing Director and Head of Healthcare Investing at MSCP.

State Mongelli, CEO of Clarity, noted the value added by Morgan Stanley during its ownership, particularly highlighting the strategic support provided by MSCP’s in-house operating expertise.

Clarity produces and delivers over 150 million member communications annually for more than 100 healthcare organizations nationwide, according to the company’s press release statement.

William Blair served as lead financial advisor to Clarity, with Lincoln International acting as financial advisor. Dechert was retained as legal counsel and Alvarez and Marsal for financial diligence.

Morgan Stanley Capital Partners focuses on privately negotiated equity investments primarily in North America across business services, consumer, healthcare, education and industrial markets. The parent company’s strong market position is reflected in its consistent dividend growth, having raised dividends for 11 consecutive years. Detailed analysis and comprehensive metrics are available in the Morgan Stanley Pro Research Report, one of 1,400+ deep-dive reports available exclusively to InvestingPro subscribers.

In other recent news, Morgan Stanley reported second-quarter 2025 earnings per share of $2.13, which marked a 17% increase compared to the previous year. This result surpassed the FactSet consensus estimate by 7.5%, though it reflected an 18% decline from the prior quarter. Additionally, Evercore ISI raised its price target for Morgan Stanley from $146 to $150, maintaining an Outperform rating and highlighting strong performances in the Wealth Management and Investment Management sectors. In contrast, Freedom Broker downgraded the firm’s stock rating from Buy to Hold, with a price target of $126. Citizens JMP reiterated a Market Perform rating, noting the company’s resilience in challenging market conditions.

Morgan Stanley also announced it would pay regular dividends on 12 series of its preferred stock, with payments scheduled for September and October 2025. In a separate development, Morgan Stanley led a banking consortium that arranged a $2 billion debt package for the financial technology company IntraFi. This financing effort, backed by Blackstone Inc. and Warburg Pincus, will enable IntraFi to distribute dividends to its private equity owners and refinance part of its higher-risk debt. These recent developments highlight Morgan Stanley’s active role in financial markets and its strategic maneuvers in the current economic landscape.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.